PRESS RELEASES

2011-10-20
Les espoirs de la médecine personnalisée
read more »

All press releases »

MEMBER LOGIN


WELCOME

WIN Consortium offers an opportunity to make an impact on personalized cancer therapy across the globe by increasing the number of patients having access to innovative clinical trials and treatment with the latest innovative drugs.

John Mendelsohn, Chairman of the WIN Consortium

2011 WIN SYMPOSIUM

Interview Alexander Eggermont

Member of the WIN Consortium Directorate and Director of Insitut Gustave Roussy (France)


View interview » 




OUR PARTNERS

Congress by design null null GE Healthcare Agilent Life Technologies null null null